Background
Long-term exposure to fine particulate air pollution, especially particles with a diameter of 2.5 micrometers or smaller (PM2.5), has long been recognized as a risk factor for cardiovascular disease. However, most public attention and regulatory action focus on pollution levels above official air-quality standards. Less is known about whether chronic exposure to PM2.5 can still affect health even when concentrations remain below the current U.S. Environmental Protection Agency annual limit of 9 μg/m3. This question matters because millions of older adults live in areas that are considered relatively clean but may still face measurable health risks.
Hypertension, or high blood pressure, is one of the most common chronic conditions in older adults and a major driver of stroke, heart attack, heart failure, kidney disease, and premature death. Hospitalization for hypertension often reflects severe blood-pressure instability, poor control of underlying disease, or complications that require urgent medical care. Understanding whether low-level air pollution contributes to these hospitalizations can help guide prevention strategies and air-quality policy.
Study Objective
This study examined whether long-term exposure to PM2.5 concentrations below the U.S. annual standard was associated with a higher risk of hospitalization for hypertension among Medicare beneficiaries aged 65 years and older across the contiguous United States from 2017 to 2022. The investigators used a causal inference approach to better estimate whether the pollution exposure itself may contribute to risk rather than simply being correlated with other factors.
Methods
The researchers built a large national cohort of more than 26 million older adults using Medicare data. Participants lived in ZIP codes where annual PM2.5 concentrations remained consistently below 9 μg/m3 throughout the study period. This design focused specifically on low-exposure settings, allowing the study to evaluate health risks even within ranges generally considered acceptable under current standards.
Because pollution studies can be influenced by unmeasured factors such as housing quality, access to medical care, lifestyle, neighborhood conditions, and underlying health differences, the authors used a double-negative control approach. In simple terms, this method helps detect and reduce bias from hidden confounders by comparing exposures and outcomes in a way that strengthens causal interpretation.
The primary outcome was hospitalization related to hypertension. The study also performed secondary analyses comparing the main results with conventional quasi-Poisson regression models. In addition, the researchers examined whether the effect of PM2.5 differed across population subgroups, including sex, geographic region, urban-rural status, and neighborhood socioeconomic conditions.
Key Findings
The study found that even small increases in PM2.5 concentration were associated with higher hospitalization risk. Specifically, each 1-μg/m3 increase in annual PM2.5 was linked to a 2.8% increase in hypertension-related hospitalization among all beneficiaries, with a 95% confidence interval of 2.5% to 3.2%. These estimates were similar to those produced by standard quasi-Poisson regression, lending support to the robustness of the findings.
The results suggest that the relationship between air pollution and blood pressure-related illness does not disappear at levels below the regulatory threshold. In other words, there may be no truly safe lower boundary for PM2.5 exposure when it comes to cardiovascular risk, particularly in older adults.
The study also identified groups that appeared more vulnerable to this association. Greater risk was observed among women, residents of the Midwest and Northeast, people living in rural or suburban areas, and individuals residing in neighborhoods with greater socioeconomic deprivation. These differences may reflect variation in baseline health status, healthcare access, environmental stressors, housing characteristics, temperature patterns, or cumulative exposure to multiple risk factors.
Why This Matters
These findings are important because they challenge the assumption that air pollution is only a concern when concentrations exceed official standards. For older adults, especially those with pre-existing hypertension or cardiovascular disease, even “low-level” PM2.5 exposure may increase the likelihood of acute blood-pressure complications severe enough to require hospitalization.
From a public health perspective, this study supports stronger efforts to reduce particulate air pollution further, even in regions that already meet current standards. It also suggests that clinicians and policymakers should think beyond threshold-based thinking and consider the potential benefits of continued air-quality improvement at low exposure levels.
Possible Biological Mechanisms
Although this study was not designed to prove mechanism, prior research offers several plausible explanations for how PM2.5 may worsen blood pressure control. Fine particles can enter the lungs, trigger systemic inflammation, and increase oxidative stress. These processes may impair blood vessel function, stiffen arteries, alter autonomic nervous system balance, and promote vasoconstriction. Over time, such effects can raise blood pressure and make hypertension harder to control.
Older adults may be especially susceptible because of age-related vascular changes, a higher burden of chronic disease, and greater use of medications that can interact with environmental stressors. Even modest pollution exposure may therefore have outsized effects in this population.
Clinical and Policy Implications
For clinicians, the study reinforces the importance of asking about environmental exposures as part of cardiovascular risk assessment, especially in older patients with difficult-to-control blood pressure. While individual patients cannot fully eliminate ambient air pollution exposure, practical steps such as staying indoors during poor air-quality days, using high-efficiency particulate air filters, and optimizing antihypertensive therapy may help reduce risk.
For policymakers, the findings suggest that current standards may not be fully protective for cardiovascular outcomes. Regulatory agencies may need to consider whether lower PM2.5 thresholds are justified based on accumulating evidence of harm at levels previously considered acceptable. Community-level interventions to reduce emissions from traffic, industry, power generation, and wildfire smoke remain essential.
Study Strengths and Limitations
A major strength of this study is its very large, nationally representative cohort of older adults, which provides strong statistical power and broad geographic coverage. The focus on areas with PM2.5 below the federal annual standard makes the findings especially relevant to current U.S. air-quality policy. The use of a causal inference framework also strengthens the interpretation of the association.
However, as with all observational studies, some limitations remain. Residual confounding is still possible despite advanced methods. Exposure was based on ZIP-code-level annual PM2.5 estimates rather than individual personal monitoring, so actual personal exposure may have differed. The study also focused on hospitalization, which captures more severe events but does not include milder cases managed in outpatient settings.
Conclusion
In a national cohort of older U.S. adults, long-term exposure to PM2.5 below the current U.S. annual standard was associated with a higher risk of hospitalization for hypertension. The findings suggest that even low-level air pollution may contribute to cardiovascular harm and that existing air-quality standards may not be sufficiently protective for older adults. Reducing PM2.5 further could offer meaningful public health benefits.
